Certain confidential information contained in this document, marked by [**], has been omitted because the information (i) is not material and (ii) would likely cause competitive harm to the Company if publicly disclosed.Collaboration Agreement • July 17th, 2020 • Freeline Therapeutics Holdings PLC • Biological products, (no disgnostic substances) • England and Wales
Contract Type FiledJuly 17th, 2020 Company Industry Jurisdiction
Certain confidential information contained in this document, marked by [**], has been omitted because the information (i) is not material and (ii) would likely cause competitive harm to the Company if publicly disclosed.Collaboration Agreement • June 29th, 2020 • Freeline Therapeutics Holdings LTD • Biological products, (no disgnostic substances) • England and Wales
Contract Type FiledJune 29th, 2020 Company Industry Jurisdiction